These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6982414)

  • 1. Induction of differentiation in a case of common acute lymphoblastic leukemia.
    Cossman J; Neckers LM; Arnold A; Korsmeyer SJ
    N Engl J Med; 1982 Nov; 307(20):1251-4. PubMed ID: 6982414
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in cell surface phenotype of T- and B-cell chronic lymphocytic leukemia cells following in vitro differentiation by phorbol ester.
    Shawler DL; Glassy MC; Wormsley SB; Royston I
    J Natl Cancer Inst; 1984 May; 72(5):1059-63. PubMed ID: 6609264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
    Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
    J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
    Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
    J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA).
    Miller RA; Gralow J
    J Immunol; 1984 Dec; 133(6):3408-14. PubMed ID: 6436381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
    Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
    Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Induction of differentiation of human myelomonocytic cell lines by chemical inducers: analysis of surface antigens with monoclonal antibodies].
    Yamada K; Okabe N; Saito H; Suzuki R
    Nihon Ketsueki Gakkai Zasshi; 1984 May; 47(3):703-8. PubMed ID: 6591672
    [No Abstract]   [Full Text] [Related]  

  • 9. Human B-lymphocyte maturation sequence revealed by TPA-induced differentiation of leukaemic cells.
    Forbes IJ; Zalewski PD; Valente L
    Immunobiology; 1982 Oct; 163(1):1-6. PubMed ID: 6983491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phorbol ester-induced differentiation of a non-T, non-B leukemic cell line: model for human lymphoid progenitor cell development.
    LeBien TW; Bollum FJ; Yasmineh WG; Kersey JH
    J Immunol; 1982 Mar; 128(3):1316-20. PubMed ID: 7035564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration in glycosphingolipid pattern during phorbol-12-myristate-13-acetate-induced cell differentiation in human T-lymphoid leukemia cells.
    Kiguchi K; Henning-Chubb C; Huberman E
    Cancer Res; 1986 Jun; 46(6):3027-33. PubMed ID: 3486042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
    Guy K; Meehan RR; Dewar AE; Larhammar D
    Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of differentiation in human T-lymphoblastic leukemia cell lines by 12-O-tetradecanoylphorbol 13-acetate (TPA): studies with monoclonal antibodies to T cells.
    Nagasawa K; Mak TW
    Cell Immunol; 1982 Aug; 71(2):396-403. PubMed ID: 6982771
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of tumor promotor on neoplastic cell transformation].
    Nagasawa K
    Nihon Rinsho; 1983; 41(2):420-32. PubMed ID: 6345854
    [No Abstract]   [Full Text] [Related]  

  • 15. [Differentiation induction of acute leukemia cells and its clinical usefulness].
    Ohta M; Saito M; Kitagawa S; Miura Y; Takaku F
    Rinsho Ketsueki; 1983 Jul; 24(7):842-9. PubMed ID: 6579318
    [No Abstract]   [Full Text] [Related]  

  • 16. Phorbol ester-induced differentiation of human T-lymphoblastic cell line HPB-ALL.
    Nakao Y; Matsuda S; Fujita T; Watanabe S; Morikawa S; Saida T; Ito Y
    Cancer Res; 1982 Sep; 42(9):3843-50. PubMed ID: 6179612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a common acute lymphoblastic leukemia cell line (LC4-1) and effects of phorbol myristate acetate (PMA) on the surface antigen expression of the cell line.
    Yoshimura T; Mayumi M; Yorifuji T; Kim KM; Heike T; Miyanomae T; Shinomiya K; Mikawa H
    Am J Hematol; 1987 Sep; 26(1):47-54. PubMed ID: 3115091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phorbol ester enhances both interleukin 2 receptor expression and immunoglobulin secretion in human Epstein-Barr virus-immortalized B cells.
    Polke CR; Lowenthal JW; Roth SA; Rohwer P; MacDonald HR; Kalden JR
    Eur J Immunol; 1986 Feb; 16(2):146-50. PubMed ID: 3007165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetate.
    Guy K; Van Heyningen V; Dewar E; Steel CM
    Eur J Immunol; 1983 Feb; 13(2):156-9. PubMed ID: 6403357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
    Hashimi L; Wang CY; Al-Katib A; Koziner B
    Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.